To date, it has not been possible to produce human SLX4-/- cancer cell lines by CRISPR-Cas9 gene editing, suggesting that SLX4 may be essential in human tumor cells (Guervilly and Gaillard 2018). The gene discussed is SLX4; the disease is cancer.